Education Series

Let’s Talk T1D: Cell Therapy

When: Thursday, October 24, 2024, 7:00 p.m. EST (French), 8:00 p.m. EST (English)

Where: Microsoft Teams (a link will be sent after registration)

Who: Hosted by JDRF and featuring Steven Paraskevas, MD, PhD, Transplant Surgeon, Director of Pancreas and Islet Transplantation & Director of Transplant Research (MUHC) and Professor, Department of Surgery, Faculty of Medicine and Health Sciences, McGill University

As part of our ongoing Let’s Talk T1D educational series, this free information session will provide an overview of current stem cell therapy clinical practices and research as a potential cure for type 1 diabetes (T1D).

Curing T1D is the primary goal of JDRF and many of the 300,000 Canadians living with T1D and their families. Cell therapy is one of the most active and fast-moving avenues of research in this area, but what is it and how close are these approaches to becoming a reality?

Cell therapy generally refers to the replacement (transplantation) of glucose-sensing, insulin-producing cells that are destroyed in a person with T1D, with the goal of the individual eventually making their own insulin again.

We’re very excited to be joined by Steven Paraskevas, MD, PhD, a leading transplant surgeon and researcher in this field, to share more about ongoing research and where we are now.

The event is open to all. We hope to see you there.

For more information on cell therapies and T1D:
https://jdrf.ca/cell-therapy/

To find actively recruiting clinical trials:
clinicaltrials.jdrf.ca

Link to register: https://jdrf.akaraisin.com/ui/EducationSeries1024